IntelliPharmaCeutics International Setting Up For New Highs
António Costa | Nov 20, 2016 01:38PM ET
IntelliPharmaCeutics International (NASDAQ:IPCI) jumped 21c, or 7.24%, on Friday to 3.11, just 22c below its 52 week high of 3.33. The stock broke its descending trend line (yellow line on chart) and could break 3.33 next on its way to a target of 3.72 to 3.98 if the volume keeps up and shorts continue to cover. From a technical standpoint, the stock is in a bull market and showing clear signs of wanting to move higher.
All major five EMAs are moving up and the stock is trading above all. Friday’s intraday high of 3.11 is the highest level the stock has touched in more than 4 weeks. The RSI indicator, which was falling towards its 50% level in the beginning of the month, turned around smartly and has more room to run before hits overbought momentum.
The MACD has climbed up above its signal line in positive territory. The daily technical chart above gives me a good indication on the trend momentum and I believe we could see new highs next week.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.